Coronary artery disease Circulatory System Coronary artery disease
Conditions
Interventions
PCI in a real world setting (chronic and acute disease). Patients randomised 2:1 to drug eluting versus bare metal stents.
Sponsors
University Hospital Basel (Switzerland)
Eligibility
Inclusion criteria
Inclusion criteria: Coronary artery disease suitable for interventional therapy. All patients referred for cardiac catheterisation and subsequent Percutaneous Coronary Intervention (PCI) irrespective of clinical indication, who are able to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. In-stent-restenosis 2. Target vessel diameter equal to or greater than 4 mm 3. No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Six month cost-effectiveness with effectiveness defined as reduction of major adverse cardiac events - i.e., cardiac death, non-fatal myocardial infarction and target vessel revascularisation. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mortality from other cause, target vessel ischemia by myocardial perfusion Single Photon Emission Computed Tomography (SPECT). 2. Effectiveness of DES in patients with myocardial infarction and saphenous vein graft disease. 3. Cost-effectiveness as defined above after 18 and 36 months. | — |
Countries
Switzerland
Outcome results
None listed